Physician

Krishna K R Manda, MD

According to 2025 Medicare claims, Krishna Manda, MD (NPI: 1558593095) practices nephrology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is KIDNEY CARE CENTER ROCKFORD LLC (NPI: 1861816167; TIN: 46-4664951) and primary practice location at 61107-5605. Manda is affiliated with the OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Manda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 616 traditional Medicare patients, billed 3,547 HCPCS/CPT codes, and received $258,696 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,195 prescription claims across 206 beneficiaries totaling $60,461 in drug costs, led by Sevelamer Carbonate (Sevelamer Carbonate). 2015 DME data shows 12 claims. Open Payments data shows 3 records totaling $60. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,197 to $258,696. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	30	99	$8,197
2016	340	1,873	$137,818
2017	440	2,343	$174,913
2018	487	2,424	$176,976
2019	548	3,084	$240,455
2020	551	3,093	$266,200
2021	491	2,441	$205,407
2022	577	3,424	$265,469
2023	617	3,903	$284,401
2024	616	3,547	$258,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	55	264	$9,313
2016	41	186	$9,821
2017	71	558	$78,343
2018	84	751	$126,584
2019	104	1,044	$145,728
2020	131	1,241	$153,600
2021	147	1,110	$122,812
2022	165	920	$126,428
2023	193	1,031	$75,268
2024	206	1,195	$60,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$1,049
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	192	234	$127
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	220	1,041	$90
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	80	98	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	419	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	306	423	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sevelamer Carbonate	Sevelamer Carbonate	45	1,676	$6,527
Lokelma	Sodium Zirconium Cyclosilicate	14	434	$6,075
Bumetanide	Bumetanide	54	3,113	$3,047
Calcium Acetate	Calcium Acetate	22	1,113	$1,530
Calcitriol	Calcitriol	94	5,523	$1,411

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$60	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Krishna K. R. Manda, MD?

Tedicare shows public-source Medicare data for Krishna K. R. Manda, MD (NPI 1558593095), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Krishna K. R. Manda, MD have ACO affiliation data?

Krishna K. R. Manda, MD is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Krishna K. R. Manda, MD?

Krishna K. R. Manda, MD is linked to KIDNEY CARE CENTER ROCKFORD LLC (billing NPI 1861816167) in the available physician profile data.

Does Krishna K. R. Manda, MD have Open Payments data?

Krishna K. R. Manda, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.